Used as a key intermediate in the synthesis of antibacterial agents, particularly in the development of oxazolidinone-class antibiotics such as those targeting multidrug-resistant Gram-positive pathogens like MRSA and VRE. This compound serves as a crucial building block that enables the final drug to inhibit bacterial protein synthesis by binding to the P-site of the 50S ribosomal subunit, thereby preventing the formation of the initiation complex. Its specific stereochemistry and functional groups enhance the potency and selectivity of the resulting antibiotics. Commonly employed in pharmaceutical research and medicinal chemistry for optimizing drug candidates against resistant bacterial infections.